OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogenetics of Methadone Response
Francina Fonseca, Marta Torrens
Molecular Diagnosis & Therapy (2017) Vol. 22, Iss. 1, pp. 57-78
Open Access | Times Cited: 23

Showing 23 citing articles:

Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine
Florence Noble, Nicolas Marie
Frontiers in Psychiatry (2019) Vol. 9
Open Access | Times Cited: 47

Current Treatments for Substance Use Disorders
A.A.B. Barros D'Sa, Andrew Gaddis, Eric C. Strain
Oxford University Press eBooks (2025), pp. 685-696
Closed Access

Neuropharmacological and Neurogenetic Correlates of Opioid Use Disorder (OUD) As a Function of Ethnicity: Relevance to Precision Addiction Medicine
Tomilowo Abijo, Kenneth Blum, Marjorie C. Gondré‐Lewis
Current Neuropharmacology (2019) Vol. 18, Iss. 7, pp. 578-595
Open Access | Times Cited: 29

Relevance of CYP2B6 and CYP2D6 genotypes to methadone pharmacokinetics and response in the OPAL study
Caroline Victorri‐Vigneau, Céline Verstuyft, Régis Bouquié, et al.
British Journal of Clinical Pharmacology (2019) Vol. 85, Iss. 7, pp. 1538-1543
Open Access | Times Cited: 20

Opioid Addiction and Treatment
Marta Torrens, Francina Fonseca, F. Dinamarca, et al.
Springer eBooks (2020), pp. 241-258
Closed Access | Times Cited: 12

Predictive Factors for Methadone Maintenance Treatment Compliance: Exploring Resistance and Tolerance in Heroin Addiction
Mina Makvand, Seyed Davood Mirtorabi, Arezoo Campbell, et al.
Iranian Journal of Psychiatry and Behavioral Sciences (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 1

Against Repurposing Methadone for Glioblastoma Therapy
Tatjana Vatter, Lukas Klumpp, Katrin Ganser, et al.
Biomolecules (2020) Vol. 10, Iss. 6, pp. 917-917
Open Access | Times Cited: 11

A genome-wide association, polygenic risk score and sex study on opioid use disorder treatment outcomes
Alannah McEvoy, Caroul Chawar, Amel Lamri, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3

Influence of CYP2B6 Genotype on Methadone Dosage in Patients from the Methadone Maintenance Treatment (MMT) Program in Pereira, Colombia
Carlos A. Arias, Oscar M. Ramirez, Juan Pablo Vélez, et al.
Life (2023) Vol. 13, Iss. 4, pp. 1038-1038
Open Access | Times Cited: 3

Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response
Xiaohu Xie, Jun Gu, Dingding Zhuang, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 11
Open Access | Times Cited: 5

A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder
Caroul Chawar, Alannah Hillmer, Stephanie Sanger, et al.
Addiction Science & Clinical Practice (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 7

Four single nucleotide polymorphisms in genes involved in neuronal signaling are associated with opioid use disorder in West Virginia
Shane W Kaski, Stephan Brooks, Sijin Wen, et al.
Journal of Opioid Management (2019) Vol. 15, Iss. 2, pp. 103-109
Open Access | Times Cited: 6

Genomic and Personalized Medicine Approaches for Substance Use Disorders (SUDs) Looking at Genome-Wide Association Studies
Danilo Cozzoli, Alessia Daponte, Salvatore De Fazio, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1799-1799
Open Access | Times Cited: 6

<p>Lack of Efficacy: When Opioids Do Not Achieve Analgesia from the Beginning of Treatment in Cancer Patients</p>
Oscar Corli, Giovanna Damia, Francesca Galli, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 10337-10344
Open Access | Times Cited: 5

Methadone Treatment for Heroin Dependence
Baconi Daniela Luiza, Anne Marie Ciobanu, Robert Daniel Vasile, et al.
InTech eBooks (2018)
Open Access | Times Cited: 4

Association study of genetic polymorphisms inGABRDwith treatment response and dose in methadone maintenance treatment
Xiaohu Xie, Jun Gu, Dingding Zhuang, et al.
Personalized Medicine (2021) Vol. 18, Iss. 5, pp. 423-430
Closed Access | Times Cited: 4

The effects of OPRM1 118A>G on methadone response in pain management in advanced cancer at end of life
Larisa M. Haupt, Alison Haywood, Heidi G. Sutherland, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Biomarkers to predict staging and treatment response in opioid dependence: A narrative review
Florence Vorspan, Cynthia Marie‐Claire, Frank Bellivier, et al.
Drug Development Research (2021) Vol. 82, Iss. 5, pp. 668-677
Open Access | Times Cited: 3

Farmacología y Epidemiología de Opioides
Jaime Cardoso‐Ortiz, María Argelia López Luna, Kajua B. Lor, et al.
Revista Bio Ciencias (2020) Vol. 7
Open Access | Times Cited: 2

Conformations and interactions comparison between R- and S-methadone in wild type CYP2B6, 2D6 and 3A4
Nik Nur Syazana Bt Nik Mohamed Kamal, Theam Soon Lim, Rusli Ismail, et al.
Physical Sciences Reviews (2019) Vol. 4, Iss. 10
Closed Access

Page 1

Scroll to top